Table 2.
Correlation of CD47 and Lewis y antigen expression with clinical features of ovarian cancer
| Features | Cases | CD47 | Lewis y | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|||||||||
| Positive cases (%) | P | High (%) | P | Positive cases (%) | P | High (%) | P | |||
| Pathological Type | ||||||||||
| Serous | 75 | 62 (82.67) | > 0.05 | 49 (65.33) | > 0.05 | 62 (82.67) | > 0.05 | 49 (65.33) | > 0.05 | |
| Mucinous | 16 | 14 (87.50) | 7 (43.75) | 13 (81.25) | 7 (43.75) | |||||
| Endometrioid | 8 | 7 (87.5) | 6 (75.00) | 8 (100) | 6 (75.00) | |||||
| OCCC | 17 | 17 (100) | 10 (58.82) | 17 (100) | 10 (58.82) | |||||
| Surgical Stage | ||||||||||
| I-II | 50 | 44 (88.00) | > 0.05 | 23 (46.00) | 0.01 | 40 (80.00) | > 0.05 | 25 (50.00) | 0.031 | |
| III-IV | 66 | 61 (92.42) | 46 (69.70) | 60 (90.00) | 46 (69.70) | |||||
| Differentiation | ||||||||||
| High | 11 | 8 (72.72) | > 0.05 | 3 (27.27) | 0.01* | 7 (63.63) | > 0.05 | 3 (27.27) | 0.013* | |
| Middle | 34 | 31 (90.32) | 18 (52.94) | 0.14* | 30 (88.24) | 21 (61.76) | 0.65* | |||
| Low | 71 | 63 (88.73) | 48 (67.61) | 63 (88.73) | 47 (66.20) | |||||
| Lymphatic Metastasis | ||||||||||
| No | 96 | 86 (89.58) | > 0.05 | 53 (55.21) | 0.04 | 81 (84.38) | > 0.05 | 52 (54.16) | 0.048 | |
| Yes | 20 | 19 (95.00) | 16 (80.00) | 19 (95.00) | 16 (80.00) | |||||
*
Compared with low differentiation group.